tion with the liver fluke, Opisthorchis viverrini, and intrahepatic bile-duct carcinoma (cholangiocarcinoma) in man is strongly suspected (Sonakul et al., 1978; Flavell, 1981) though not yet conclusively proven. The liver pathology of opisthorchiasis has been adequately described in man (Tansurat, 1971) and well studied in the hamster Flavell et al., 1980b) , though in our experience life-time infections in golden Syrian hamsters do not result in the production of bile-duct tumours.
The hypothesis has been presented that liver-fluke infection of man renders the biliary epithelium more susceptible to malignant transformation by chemical or other exogenous carcinogenic stimuli (Flavell, 1981; Gibson & Chan, 1972; Thamavit et al., 1978 (Flavell et al., 1980b) . Forty-one days after infection, a single oral dose of 1P6 mg. DMN was given to group 1 and 2 animals via a dosing needle. At this time after infection, parasites have matured and begun egg production in the extraand intra-hepatic bile ducts (Flavell, unpublished) . Moreover, we (Flavell et al., 1980b) and others have shown that biliary hyperplasia starts within the first 2 weeks of infection in the hamster and that by 41 days after infection biliary epithelial proliferation, particularly of the second order bile ducts where parasites preferentially reside, is well established.
To confirm that infections had been established in all animals from Groups 1 and 3, faecal pellets were collected from each animal just before administration of DMN, and screened for the presence of eggs by a previously described method (Flavell et al., 1980a animals. This clearly suggests the possibility that liver-fluke infection predisposes the hamster host to the long-term effects of DMN toxicity.
Five intrahepatic cholangiocarcinomas were found in animals receiving parasites and DMN (Group 1) but no malignant bileduct tumours were found in any of the animals from Groups 2 and 3. Benign cystic cholangiomas were however found commonly in animals from both groups 1 and 2. All 5 bile-duct tumours showed invasion into adjacent blood vessels and normal tissues. Three of the tumours produced copious amounts of mucin and goblet-cell metaplasia was very pronounced in all (Fig. 2) . The first cholangiocarcinoma was discovered only 18 weeks after DMN treatment and was not mucussecreting (Fig. 3) . The remaining 4 bileduct tumours were discovered in the 21st, 29th (2 tumours) and 42nd weeks after DMN treatment and all but one were mucus-secreting. In earlier studies Thamavit et al. (1978) succeeded in producing cholangiocarcino-mas in all 0. viverrini-infected hamsters given 0 0025% DMN in the drinking water over a 10-week period. Tumours appeared within 18 weeks of starting DMN treatment. The results of this study are however of limited value as the dose and route of administration of DMN chosen produces a high incidence of cholangiocarcinomas in normal hamsters without an attendant 0. viverrini infection (Tomatis et al., 1964) . The study does little therefore to show a real increased susceptibility of the biliary epithelium in the 0. viverriniinfected hamster host to malignant transformation by DMN, though it does show that infection decreases the latent period between DMN application and tumour appearance.
A dose of DMN normally incapable of inducing cholangiocarcinomas in Golden Syrian hamsters was thus chosen for the present study (Tomatis & Cefis, 1967) . The induction of cholangiocarcinomas in animals from the worm-bearing group but not the non-infected group, animals from both groups which had received a single oral dose of DMN, strongly suggests potentiation of the cholangiocarcinogenic effectiveness of DMN by the parasite. The most outstanding pathological lesion of opisthorchiasis in both man and the hamster is biliary hyperplasia (Hou, 1955; Flavell et al., 1980b) . In the present study DMN was administered to infected animals at a time when bile-duct hyperplasia was well pronounced. It seems probable that proliferating biliary epithelial cells are more susceptible to the carcinogenic action of DMN than their quiescent non-dividing counterparts in healthy animals without liver-fluke infection. Such is the case with proliferating hepatocytes, in which a single dose of DMN given to rats during the period of restorative hyperplasia following partial hepatectomy results in a high yield of hepatocellular carcinomas (Craddock, 1971 (Craddock, , 1975 .
It is interesting and perhaps significant to note that 3 of the 5 cholangiocarcinomas found in animals from the present study were abundant mucin-producers. A distinctive feature of the majority of cholangiocarcinomas arising in liver-flukeinfected humans is their outstanding mucin production ) and this as a common link between the experimental animal model described here and the disease in man lends some further support to the possibility of a common aetiology of the two conditions.
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